Diphenylhydantoin-induced gingival overgrowth in man: a clinico-pathological study.
In a cross-sectional, epidemiological study of diphenylhydantoin-induced gingival overgrowth (DGO) in 60 epileptic patients, gingival lesion severity was statistically compared with other clinical, laboratory, and histopathological findings. Evident DGO was observed in 50% of patients, and positive correlations were detected between overgrowth severity and oral debris, calculus accumulation, plaque score, gingival inflammation, and probing depth. However, no valid correlation was observed between lesion and patient age, mouth breathing, daily drug dose, plasma diphenylhydantoin level, or duration of drug intake. Also, there were no significant correlations between connective fiber richness and the intensity of epithelial hyperplasia and severity of gingival overgrowth.
Peñarrocha-Diago
M
M
Section of Oral Medicine, Faculty of Medicine and Dentistry, Valencia, Spain.
Bagán-Sebastián
J V
JV
Vera-Sempere
F
F
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D003238:Connective Tissue / Q000473:pathology; D004848:Epithelium / Q000473:pathology; D005260:Female; D005881:Gingiva / Q000473:pathology; D005885:Gingival Hyperplasia / Q000139:chemically induced* / Q000473:pathology; D005891:Gingivitis / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009910:Oral Hygiene; D009911:Oral Hygiene Index; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D013997:Time Factors
D010672:Phenytoin